Type 2 diabetes risk: Lowered with omega-3s

High concentrations of serum long-chain omega-3 fatty acids may help reduce the risk of type 2 diabetes, according to a University of Eastern Finland study published recently in Diabetes Care. The sources of these fatty acids are fish and fish oils. » Full article

TRENDING NOW

Check out this week's top searches
from your colleagues.

1. Obamacare: Young adults make up 24% of current Obamacare enrollees

2. Oral anticoagulants: New oral anticoagulants increase risk for GI bleeding: Study

3. Acetaminophen dosing: FDA: Prescribers, dispensers should stop use of combination painkillers with more than 325 mg of acetaminophen

4. JNC 8: 2014 evidence-based guideline for the management of high blood pressure in adults

5. Pharmacist provider status: Recognizing pharmacists as healthcare providers

Continuing Education

New CPE: Clinical Updates in Diabetes Care

This month, Drug Topics offers “Clinical Updates in Diabetes Care,” a knowledge-based activity worth up to 2 credits. The goal of this activity is to assist pharmacists in recognizing and understanding the changes in diabetes care to provide optimal evidence-based care for patients with diabetes. To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to log in.

Announcement: Welcome to the new user registration process. This new process requires all pharmacists and pharmacy technicians to provide or update their NABP e-Profile ID in order to electronically keep track of CPE credits from ACPE-accredited providers. If you have not done so, you can obtain your NABP e-Profile ID now at www.MyCPEmonitor.net. This profile will enable you to have one login for all the NABP programs and services you will need throughout your career.

Fulyzaq improves noninfectious diarrhea in patients with HIV on ART therapy

Noninfectious diarrhea in patients with HIV on antiretroviral therapy showed improvement after treatment with 125-mg delayed-release crofelemer (Fulyzaq, Salix Pharmaceuticals) tablets, according to a study in HIV Clinical Trials. » Full article

• Emerging therapies for treating type 2 diabetes

• INFOGRAPHIC: The current state of HIV therapy

RESOURCES

Drug Watch

Latest Clinical News